A dominant-negative isoform of IKAROS expands primitive normal human hematopoietic cells.
about
Transcription factor-mediated reprogramming toward hematopoietic stem cellsDistinct signaling programs control human hematopoietic stem cell survival and proliferation.A novel signalling screen demonstrates that CALR mutations activate essential MAPK signalling and facilitate megakaryocyte differentiation.Molecular landscapes of human hematopoietic stem cells in health and leukemia.Leukaemic alterations of IKZF1 prime stemness and malignancy programs in human lymphocytes.A Prospective Analysis of Human Leukemogenesis
P2860
A dominant-negative isoform of IKAROS expands primitive normal human hematopoietic cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
A dominant-negative isoform of IKAROS expands primitive normal human hematopoietic cells.
@en
A dominant-negative isoform of IKAROS expands primitive normal human hematopoietic cells.
@nl
type
label
A dominant-negative isoform of IKAROS expands primitive normal human hematopoietic cells.
@en
A dominant-negative isoform of IKAROS expands primitive normal human hematopoietic cells.
@nl
prefLabel
A dominant-negative isoform of IKAROS expands primitive normal human hematopoietic cells.
@en
A dominant-negative isoform of IKAROS expands primitive normal human hematopoietic cells.
@nl
P2093
P2860
P1433
P1476
A dominant-negative isoform of IKAROS expands primitive normal human hematopoietic cells
@en
P2093
Connie J Eaves
Elizabeth Bulaeva
Gabrielle Rabu
Kingsley Shih
Nagarajan Kannan
Nima Aghaeepour
Paul H Miller
Philip A Beer
Shabnam Rostamirad
P2860
P304
P356
10.1016/J.STEMCR.2014.09.006
P577
2014-10-11T00:00:00Z